Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Results from a single-arm, multi-institutional Phase II study Of multi-agent intrathecal and systemic Cchemotherapy with age- and risk-adapted radiation therapy for children with newly diagnosed CNS Atypical Teratoid/Rhabdoid Tumor

Susan N. Chi MD; William Fletcher; Xiaopan Yao PhD, Kenneth Cohen MD; Michael Fisher MD, Jacklyn Biegel PhD; Anna Janss MD; Stewart Goldman MD; Daniel Bowers MD; Peter Manley MD; Claire Mazewski MD; Anne Bendel MD; Joshua Rubin, MD PhD; Christopher D. Turner MD; Charles Roberts MD PhD; Karen Marcus MD; Liliana Goumnerova MD; Nicole Ullrich MD PhD; Christine Chordas PNP; Mary Ann Zimmerman PNP; Mark W. Kieran MD PhD. Results from a single-arm, multi-institutional Phase II study Of multi-agent intrathecal and systemic Cchemotherapy with age- and risk-adapted radiation therapy for children with newly diagnosed CNS Atypical Teratoid/Rhabdoid Tumor. Neuro-oncol. 2008; 10(3):373.


© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.